US Patent 11505620 Methods of detecting plasma kallikrein
Patent 11505620 was granted and assigned to Takeda Pharmaceutical Company on November, 2022 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11505620 Methods of detecting plasma kallikrein
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
